caseins has been researched along with irinotecan in 2 studies
Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (irinotecan) | Trials (irinotecan) | Recent Studies (post-2010) (irinotecan) |
---|---|---|---|---|---|
16,863 | 561 | 4,170 | 8,002 | 1,885 | 3,752 |
Protein | Taxonomy | caseins (IC50) | irinotecan (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 2.7 | |
Interstitial collagenase | Homo sapiens (human) | 6.06 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.556 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.171 | |
Acetylcholinesterase | Homo sapiens (human) | 1.827 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.9 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 4.7667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assaraf, YG; Epstein, D; Livney, YD; Shapira, A | 1 |
Assaraf, YG; Bar-Zeev, M; Kelmansky, D; Livney, YD | 1 |
2 other study(ies) available for caseins and irinotecan
Article | Year |
---|---|
Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on co-assembly.
Topics: Administration, Oral; Antineoplastic Agents; Camptothecin; Caseins; Colloids; Docetaxel; Drug Carriers; Drug Compounding; Drug Stability; Hydrogen-Ion Concentration; Irinotecan; Molecular Structure; Nanoparticles; Paclitaxel; Particle Size; Structure-Activity Relationship; Taxoids; Vinblastine | 2010 |
β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.
Topics: Acridines; Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Caseins; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Irinotecan; Micelles; Nanoparticles; Neoplasm Proteins; Stomach Neoplasms; Tetrahydroisoquinolines | 2018 |